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A method and apparatus for characterizing the time and frequency response of an 
ultrasonically reflective contrast agent is disclosed. An ultrasonically reflective 
contrast agent is injected, under constant pressure1 into a fluid flowing through a 
pump flow circuit. The fluid and the ultrasonically reflective contrast agent are 
uniformly mixed in a mixing chamber, and the uniform niixture is passed through a 
contrast agent chamber. The contrast agent chamber is acoustically and axially 
interposed between an ultrasonic transducer chamber and an acoustic isolation 
chamber. A pulse of ultrasonic energy is transmitted into the contrast agent 
chamber from the ultrasonic transducer chamber. An echo waveform is received 
from the ultrasonically reflective contrast agent, and it is analyzed to determine the 
time and frequency response of the ultrasonically reflective contrast agent. 
Novelty is believed to reside in both the entire method and the apparatus. 
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METHOD AND APPARATUS TO CHARACTERIZE 
ULTRASONICALLY REFLECTIVE CONTRAST AGENTS 
0riai"of the Invention 
5 
The invention described herein was made in the performance of work under a 
NASA contract and is subject to  the provisions of Section 305 of the National 
Aeronautics and Space Act of 1958, as amended, Public Law 85-568 (72 Stat. 435 
42 U.S.C. 2457). 
10 
One method of medical ultrasonic imaging involves the use of ultrasonically 
reflective contrast agents. Such contrast agents enhance the image obtained in clinical 
15 studies by increasing the contrast of and by outlining the anatomic structures being 
studied, e.g., the heart (its chambers, blood vessels, and tissue). Examples of 
commercially available ultrasonically reflective contrast agents include, "ALBUNEXw 
brand ultrasonically reflective contrast agent manufactured by Molecular Biosystems, 
San Diego, California, and "ECHOVIST" brand ultrasonically reflective contrast agent 
20 manufactured by Schering Corporation, Germany. 
New contrast agents should be studied in the laboratory to  characterize their 
time and frequency responses to ultrasonic energy before they are used with patients. 
An analysis system is therefore needed in order to  characterize the time and frequency 
responses of particular ultrasonically reflective contrast agents, and so that one 
25 ultrasonically reflective contrast agent may be compared with another ultrasonically 
reflective contrast agent. 
Summary 
30 The present invention is directed to  a method and an apparatus that satisfies the 
need for an analysis system for characterizing the time and frequency response of 
ultrasonically reflective contrast agents. A method of characterizing the time and 
frequency response of an ultrasonically reflective contrast agent having the features of 
the present invention includes the steps of injecting, under constant pressure, the 
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ultrasonically reflective contrast agent into a fluid stream. The fluid stream is passed 
through a mixing chamber so as to uniformly mix the ultrasonically reflective contrast 
agent and the fluid flowing in the fluid stream. The uniform mixture of the ultrasonically 
reflective contrast agent and the fluid is passed through a contrast agent chamber, and 
5 a pulse of ultrasonic energy is transmitted into the contrast agent chamber. An echo 
waveform is received from the ultrasonically reflective contrast agent, and it is analyzed 
to determine the time and frequency response of the ultrasonically reflective contrast 
agent. 
Another method of characterizing the time and frequency response of an 
10 ultrasonically reflective contrast agent having the features of the present invention 
includes the step of injecting, under constant pressure, an ultrasonically reflective 
contrast agent into a fluid flowing through a pump flow circuit. The fluid is passed 
through a mixing chamber so as to uniformly mix the ultrasonically reflective contrast 
agent and the fluid. The uniform mixture of the ultrasonically reflective contrast agent 
15 and the fluid is passed through a contrast agent chamber that is acoustically interposed 
between an acoustic isolation chamber and an ultrasonic transducer chamber. A pulse 
of ultrasonic energy is transmitted into the contrast agent chamber from the ultrasonic 
transducer chamber. An echo waveform is received from the ultrasonically reflective 
contrast agent, and it is analyzed to determine the time and frequency response of the 
20 ultrasonically reflective contrast agent. 
An apparatus for analyzing an ultrasonically reflective contrast agent having the 
features of the present invention comprises a fluid that is pumped through a pump flow 
circuit, and an injector filled with the ultrasonically reflective contrast agent for injecting 
the ultrasonically reflective contrast agent into the fluid under constant pressure. The 
25 mixture of the injected ultrasonically reflective contrast agent and the fluid is uniformly 
mixed in a mixing chamber and then passed into a contrast agent chamber. A pulse of 
ultrasonic energy is transmitted by an ultrasonic transducer into the contrast agent 
chamber, and the echo waveform from the ultrasonically reflective contrast agent is 
received by the ultrasonic transducer for analysis to determine the time and frequency 
30 characteristics of the ultrasonically reflective contrast agent. 
The present invention is also directed toward a method of analyzing an 
ultrasonic echo waveform received from an ultrasonically reflective contrast agent. The 
method includes the steps of digitizing the echo waveform into discrete data points, and 
computing mean amplitude data points from the discrete data points. Spurious mean 
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amplitude data points are corrected, and the mean amplitude data points are smoothed. 
The mean amplitude data points are plotted against time, and parameter calculations 
are performed on the plot of the mean amplitude data points against time curve. 
5 Drawinas 
For a more complete understanding of the present invention reference should 
be made to the description, which is set forth below. This description should be read 
together with the accompanying drawings, wherein: 
10 Figure 1 is a schematic diagram of the present invention. 
Figures 2a and 2b comprise a two-part diagram of typical ultrasonic waveforms 
transmitted and received by the ultrasonic transducer. 
Figure 3 is an overview flow diagram of the method of analyzing the echo 
waveform. 
15 Figure 4 is a flow diagram of the routine for computing the mean amplitude data 
points from the discrete data points. 
Figure 5 is a flow diagram of the routine for computing spurious mean amplitude 
data points. 
Figure 6 is a flow diagram of the routine for smoothing the mean amplitude data 
20 points. 
Figure 7 is a flow diagram of the routine for calculating the curve peak value. 
Figure 8 is a flow diagram of the routine for calcula-ting the time interval from 
the injection of the ultrasonically reflective contrast agent, the curve baseline or bias 
value, and the curve noise threshold. 
2 5 Figure 9 is a flow diagram of the routine for calculating the time from injection 
of the ultrasonically reflective contrast agent to the noise threshold time point for the 
curve ascending. 
Figure 10 is a flow diagram of the routine for calculating the time interval from 
the noise threshold point to the amplitude point halfway between the noise threshold 
30 point and the curve peak point for the ascending portion of the curve. 
Figure 11 is a flow diagram of the routine for calculating the area under the 
mean amplitude data points against time curve. 
Figure 12 is a typical mean amplitude data points against time curve. 
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Description 
Figure 1 illustrates the present invention. A fluid 30 contained within a reservoir 
32 is pumped through a pump flow circuit. The pump flow circuit comprises a pipe 34, 
5 a pump 36, a pipe 38, a three-way valve 40, a pipe 42, a mixing chamber 44, a pipe 
46, a contrast agent chamber 48, and a pipe 50 which serves as the pump flow circuit 
discharge. The fluid 30 preferably is either distilled water or saline solution, but it may 
comprise any fluid which is suitable for mixing with an ultrasonically reflective contrast 
agent. The pump 36 preferably is a variable speed pump. Such a pump will allow the 
10 flow parameters of the present invention to be varied in order to determine the result 
and effects on the echo waveform. Such information can be extra-polated to clinical 
situations. 
Referring again to Figure 1, a tube 52 is attached to the valve 40. A syringe 54 
having a plunger 56 is within the tube 52. The syringe 54 is connected to the three- 
15 way valve 40. The three-way valve 40 prevents backfilling of the syringe 54 with the 
fluid 30. The syringe 54 is filled with an ultrasonically reflective contrast agent 55 to 
be analyzed by the present invention. A weight 58 is placed above the plunger 56 and 
is held in place by a trigger release mechanism 60. The trigger release mechanism 60 
may comprise any device known in the art such as removable pin placed through both 
20 the tube 52 and the 58, or an electromechanical device controllable by a computer 92. 
The level of the weight 58 compared to the plunger 56 may be adjusted by a weight 
level adjust 62. The weight level adjust 62 may comprise any device known in the art 
such as a friction collar or a releasable screw thread. The purpose of the weight level 
adjust is to allow the positioning of the weight 58 so that it is just above the plunger 
25 56. This prevents the microspheres comprising the ultrasonic contrast agent 55 from 
being damaged from a sudden impulse caused by the weight 56 from striking the 
plunger 56. 
The ultrasonically reflective contrast agent 55 is caused to be injected into the 
fluid 30, under constant pressure, at the three-way valve 40 when the trigger release 
30 mechanism 60 is released because the weight 58 presses down upon the plunger with 
a constant force. The constant pressure, in addition to preventing the destruction of 
the ultrasonically reflective contrast agent 55, eliminates the variability of injection rate 
inherent with manual injection. The weight 58, the trigger release mechanism 60, and 
the weight level adjust 62 may all be replaced with a mechanical or an electro- 
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mechanical actuator. 
The fluid 30 and the ultrasonically reflective contrast agent 55 f low out of the 
three-way valve 40, through the pipe 42, and into a mixing chamber 44. The mixing 
chamber 44 is cylindrical in shape. Its purpose is to  create a rotational f low having 
5 minimal turbulence to  promote uniform mixing of the fluid 30 and the ultrasonically 
reflective contrast agent 55. 
The uniform mixture of the fluid 30 and the ultrasonically reflective contrast 
agent 55 exit the mixing chamber 44 through the pipe 46 and enter the contrast agent 
chamber 48. The contrast agent chamber 48 is cylindrical in shape to  prevent 
10 turbulence in the fluid flow. The volume of the contrast agent chamber 48 may be 
varied by  changing its size. The contrast agent chamber 48 is sealed on one side by  
a gasket 64 and a membrane seal 66, and on the other side by  a gasket 68 and a 
membrane seal 70. The gaskets 64 and 68 may be comprised of any suitable material 
such as rubber, and the membrane seals 66 and 70 may also comprise any suitable 
15 material such as vinyl food wrap. 
The contrast agent chamber 48 is acoustically interposed and axially aligned 
between t w o  additional cylindrical chambers, an acoustic isolation chamber 72 and an 
ultrasonic transducer chamber 74. The acoustic isolation chamber 72 has the same 
diameter as the contrast agent chamber 48. One side of the acoustic isolation chamber 
20 is sealed with a plate 76, while the other side is sealed wi th  a gasket 78 and with the 
membrane seal 70. The acoustic isolation chamber 72 is filled with a liquid 73 which 
may preferably be water or saline solution. The purpose of the acoustic isolation 
chamber 72 is t o  acoustically isolate the contrast agent chamber 48 so that the 
ultrasonic signal properties of the ultrasonically reflective contrast agent 55 may be 
25 studied. 
The ultrasonic transducer chamber 74 has the same diameter as the contrast 
agent chamber 48. One side of the ultrasonic transducer chamber 74 is sealed with a 
gasket 80 and with membrane seal 66. The other side of the ultrasonic transducer 
chamber 74 is sealed with a seal 82. An ultrasonic transducer 84 is mounted at the 
30 center point of the seal 82. The gaskets 78 and 80 may be comprised of any suitable 
material, such as rubber, while the seal 82 can be any suitable material strong enough 
to  support the ultrasonic transducer 84. The ultrasonic transducer chamber 74 is filled 
wi th  a liquid 86 which may preferably be water or saline solution. 
A conventional medical ultrasonic echocardiography scanner 88 supplies radio 
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frequency energy to the ultrasonic transducer 84 and receives a radio frequency echo 
waveform back from the ultrasonic transducer 84. Medical ultrasonic echocardio- 
graphy scanners such as those manufactured by General Electric Medical Systems, 
Milwaukee, Wisconsin, and by Advanced Technology Laboratories, Bothell, 
5 Washington, may be used in the present invention. 
The ultrasonic echocardiography scanner 88 produces a radio frequency output 
corresponding to the radio frequency echo waveform from the ultrasonic transducer 84. 
It is fed to an interface electronics module 90 which digitizes the echo waveform into 
discrete data points. A LeCroy Model No. 9450A oscilloscope, manufactured by 
10 LeCroy Company, Chestnut Ridge, New York, may be utilized to digitize the echo 
waveform. The digitized waveform is then fed to the computer 92, which may, for 
example, be a Compaq 486, for analysis and computation of the parameters of the 
waveform. 
Figure 2a illustrates a typical waveform of a pulse of ultrasonic energy from the 
15 ultrasonic transducer 84. The pulse of energy starts at time t and continues until time 
t . With no ultrasonically reflective contrast agent present in the contrast agent 
chamber 48, the only reflections or echos received by the ultrasonic transducer 84 are 
those from the membrane seal 66, represented by a typical waveform beginning at time 
t and continuing until time t , and from membrane seal 70, represented by a typical 
20 waveform beginning at time t and continuing until time t . Figure 2b is identical to 
Figure 2a, except that it shows a typical echo waveform of the ultrasonically reflective 
contrast agent 55 when it is present in the contrast agent chamber 48. This waveform 
begins at time t and continues until time t . 
Figure 3 is an overview flow diagram of the steps of analyzing the echo 
25 waveform. As depicted in block 94, the ultrasonically reflective contrast agent 55 is 
injected into the fluid 30 flowing through the pump flow circuit. The ultrasonically 
reflective contrast agent 55, once injected, passes through the contrast agent chamber 
48. As the ultrasonically reflective contrast agent 55 passes through the contrast 
agent chamber 48, the ultrasonic transducer 84 transmits a pulse ultrasonic energy, as 
30 depicted by block 96, and receives the echo waveform as depicted by block 98. The 
echo waveform is then digitized into discrete data points, as depicted by block 100, and 
mean amplitude data points are computed by the computer 92 from the discrete data 
points, as illustrated in block 102. The mean amplitude data points are processed by 
the computer 92 to correct spurious mean amplitude data points, as depicted by block 
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104, and the mean amplitude data points are then smoothed, again by the computer 
92, as illustrated by block 106. The next step is to plot the mean amplitude data points 
against time as shown by block 108, and to use the computer 92 to perform parameter 
calculations on the plot of the mean amplitude data points against time curve, as 
5 depicted by block 11 0. The parameter calculations are performed on the smoothed 
mean amplitude data points stored in the computer 92. 
Figure 4 is a flow diagram of the routine utilized by the present invention to 
compute the mean amplitude data points from the discrete data points. The first step 
in this routine is to acquire "N" discrete data points which represent the echo waveform 
10 X(n), from the digitizer, or interference electronics module 90, as depicted by block 
11 2. The absolute value of the discrete data points is averaged, as depicted in block 
114, to obtain a mean amplitude data point, and the mean amplitude data point is 
stored, as illustrated by block 1 16, under a time index address. After a prescribed time 
delay, the time increment address is incremented, as illustrated by block 11 8, and a 
15 decision is made to repeat the sequence, as depicted by decision block 120, based on 
whether or not any ultrasonically reflective contrast agent 55 remains in the contrast 
agent chamber 48. This may be determined physically by watching the discharge from 
the pump flow circuit or electronically by programming the computer 92 to sense when 
a waveform of the type illustrated by Figure 2a is present. If the computer 92 
20 determines that the decision at block 120 is "YES", then the return block 122 returns 
the computational flow to block 104 of Figure 3 for correction of spurious mean 
amplitude data points. 
A flow diagram of the routine to correct spurious mean amplitude data points 
is illustrated in Figure 5. This routine involves comparing each mean amplitude data 
25 point to a running average of a number of time-related points. If the given point varies 
too greatly from that average, then a substitution is made of the running average for 
that point. Referring to Figure 5, a mean amplitude data point is acquired from the 
memory of the computer 92, as depicted by block 124. This data point, as depicted 
by decision block 126, is compared a running average of a number "Lw of mean 
30 amplitude data points to determine if the data point is inside or outside of the running 
average plus or minus a predetermined range value. If the particular data point is 
outside of the running average plus or minus the predetermined range, the running 
average is replaced for that data point, as illustrated by block 128, and the 
computational flow proceeds to a decision block 130. If the particular data point is 
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inside of the running average plus or minus the predeter- mined range, the computer 92 
returns the computational flow to block 124, as illustrated by decision block 130. Once 
all of the stored values are processed, the computer 92 returns the computational flow, 
as illustrated by return block 132, to block 106 of Figure 3. 
5 To smooth the mean amplitude data points, a running average of a prescribed 
number "J" of time related data points is substituted for each mean amplitude data 
point. The subroutine which performs this function is illustrated by the flow diagram 
illustrated in Figure 6. A mean amplitude data point is acquired from the memory of the 
computer 92, as depicted by block 134. This data point is replaced by a running 
10 average of a number of mean amplitude data points, as illustrated by block 136. If all 
of the values have not been processed, decision block 138 returns the computational 
flow to block 134; and if all of the values have been processed, the computational flow 
is return by return block 140 to block 108 of Figure 3. 
The computer 92 is used in the present invention to calculate a variety of 
15 parameters that relate to the mean amplitude data points against time curve. These 
parameters include the curve peak value, time to curve peak, curve baseline, curve 
noise threshold, and the time interval from the start of injection to the point of noise 
threshold for the ascending curve and for the descending curve. Other parameters 
include the time interval from the point at which the curve exceeds the noise threshold 
20 to the time of the peak curve, and the time of appearance of the contrast agent in the 
contrast agent chamber. Additional parameters include the time from the noise 
threshold point to the amplitude point halfway between the noise threshold point forthe 
curve ascending and descending, the slope of the curve at the one half peak amplitude 
ascending and descending points, and the area under curve. 
2 5 Figure 7 is a flow diagram of the routine used by the computer 92 to calculate 
the curve peak value. The value of "XMAX" is first set to zero and a data point index, 
"n," is also set to zero, as illustrated by block 142. A mean amplitude data point is 
acquired from the memory of the computer 92, as illustrated by block 144. This value 
is compared, as illustrated by decision block 144 to the value of XMAX. If the value 
30 of the particular mean amplitude data point greater than XMAX, then XMAX. as 
illustrated by block 148, is set to the value of the mean amplitude data point and the 
data point index "nu is incremented as illustrated by block 150. If the value of the 
particular mean amplitude data point is less than XMAX, then only the data point 
register "n" is incremented. Processing continues until all of the mean amplitude values 
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are processed, as illustrated by decision block 152. The next step of this routine, as 
represented by block 154, is to set "PEAK" equal to XMAX, and to set n to the time 
index of the peak value. The computer 92 then returns to block 110 of Figure 3, as 
depicted by return block 156. 
5 The next routine, illustrated by Figure 8, calculates the time interval from the 
injection of the ultrasonically reflective contrast agent 55 into the fluid 30, the curve 
baseline or bias value over a prescribed window of initial time related points that occur 
before injection of the ultrasonically reflective contrast agent 55, and the curve noise 
threshold. As illustrated by block 158 Figure 8, the time index "nw of the peak value, 
10 determined in block 154, is acquired by the computer 92. The time to curve peak from 
the injection of the ultrasonically reflective contrast agent 55 is determined in block 160 
by multiplying n by the sampling time interval. The curve baseline is calculated in block 
162 by averaging a predetermined number "W" of time related points that occur before 
the injection of the ultrasonically reflective contrast agent 55. The noise threshold 
15 value, calculated in block 164, is determined by taking the difference between the peak 
and baseline values and multiplying that difference by an arbitrary percent value, e.g. 
10%. Thus, the mean amplitude values of the curve will have to exceed the noise 
threshold value before they will be considered in the computations. At the conclusion 
of these computations, the computer 92 then returns the computational flow to block 
20 110 of Figure 3, as illustrated by return block 166. 
Figure 9 illustrates the routine for calculating the time from the injection of the 
ultrasonically reflective contrast agent 55 into the fluid 30 to the noise threshold time 
point for the curve ascending. What is desired is the time index of the mean amplitude 
value closest to the noise threshold value. The routine operates by first setting the 
25 curve data point index "n" to zero, as illustrated by block 168. A mean amplitude data 
point is acquired from the memory of the computer 92, as illustrated by block 170, and 
a comparison is made in decision block 172 to determine if the mean amplitude data 
pointiis near the noise threshold point. If the noise threshold is within a range of each 
mean amplitude data point value plus or minus a prescribed range value, then that is 
31) the noise threshold point. To determine the actual time to the noise threshold point in 
seconds, the time index of the mean amplitude data point within the point range is 
multiplied by the sampling time interval to yield the value "THRTIMUP," as illustrated 
by block 174. If the noise threshold value does not fall within the point range, then the 
next point is examined. If the noise threshold value cannot be found to fall within any 
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- point range up to the curve peak point, then the range value is increased and the point 
comparisons are repeated until the noise threshold value falls within a point range which 
is the closest data point to the noise threshold value. These steps of the routine are 
illustrated by decision block 176 and by block 178. At the conclusion of this routine, 
5 the computer 92 returns the computational flow to block 1 10 of Figure 3, as illustrated 
by return block 180. 
The routine of Figure 9 is repeated for the portion of the descending curve to 
find the point at which the curve drops back below the noise threshold. In this routine, 
however, the curve data point index "nu of block 168 is set to the peak point index 
10 value; the "nn index comparison of decision block 176 is made to the last point index 
value rather than to the peak point index value; and the value of the actual time, in 
seconds, from the noise threshold point, is indicated by the value "THRTIMDN." The 
time from the point at which the curve exceeds the noise threshold to the time of the 
peak of the curve, or "TIM2PEAK," is calculated by the computer 92 by taking the 
15 difference between the time at which the curve exceeds the noise threshold and the 
time of the peak of the curve. The time of appearance of the ultrasonically reflective 
contrast agent 55 in the contrast agent chamber 48 is also determined by taking the 
time interval difference between the points where the curve crosses the ascending and 
descending noise threshold points, ascending and descending noise threshold points, 
20 i.e., THRTIMUP -THRTIMDN = time of appearance. 
Figure 10 illustrates the routine for calculating the time interval from the noise 
threshold point to the amplitude point halfway between the noise threshold point and 
the curve peak point for the ascending portion of the curve. What is desired is the time 
index of the mean amplitude value closest to the half-time ascending and half-time 
25 descending amplitude values. The routine operates by first determining the half-peak 
value, described as "HALFPEAK" in block 182, by multiplying the difference between 
the peak and baseline valves by 0.5. The next step, illustrated in block 184, is to set 
the curve data point index, "n," to zero. A mean amplitude data point is acquired from 
the memory of the computer 92, as illustrated by block 186, and a comparison is made 
30 in decision block 188 to determine if the mean amplitude data point is near the 
threshold point. If the half-time value is within a range of each data point value plus 
or minus a prescribed range value, then that is the half-time point value. To determine 
the actual half-time value in seconds, the time index of the mean amplitude data point 
within the point range is multiplied by the sampling time interval to yield the value 
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" 1 /2TIMUP," as illustrated by block 1 90. 
If the half-time value does not fall within that point range, then the next point 
is examined. If it cannot be found to fall within any point range up to the curve peak 
point, then the range value is incremented and the point comparisons repeated until the 
5 half-time value falls within a point range which is the closest data point to the half-time 
value. These steps of the routine are illustrated by blocks 192 and 194. At the 
conclusion of this routine, the computer 92 returns the computational flow to block 1 10 
of Figure 3, as illustrated by the return block 196. 
The routine of Figure 10 is repeated for the portion of the descending curve. 
10 In this routine, however, the curve data point index "nu of block 184 is set to the peak 
point index value; the "nu index comparison of decision block 192 is made to the last 
point index value rather than to the peak point index value; and the value of the actual 
time, in seconds, in indicated by the value "112TIMDN." 
The slope of the curve at the half-time ascending and descending points is 
15 calculated by the computer 92 by taking the difference between two bracketing time 
related points and dividing by the number of points between the values. Then dividing 
by the time interval between each point gives the slope in amplitude units per second. 
The formulas for the slopes are: 
20 112 TlMUP SLOPE = 
+ INDEX SPREAD) - X (112 TlMUP INDEX1 x (112 TlMUP INDEX 
(INDEX SPREAD) (SAMPLING TlME VALUE) 
25 
and 
112 TlMDN SLOPE = 
30 x (112 TlMDN INDEX + INDEX SPREAD) - x (112 TlMDN INDEX) 
(INDEX SPREAD) (SAMPLING TlME VALUE) 
Figure 11 illustrates the routine to calculate the area under mean amplitude data 
points against time curve. A typical curve is depicted in Figure 12. The area is 
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computed by multiplying each amplitude point by the time interval between the points 
and summing the result. The routine begins at block 198 by setting the data point 
index "nu to zero. A mean amplitude data point is acquired from the memory of the 
computer 92, as illustrated by block 200, and the area under the curve is calculated, 
5 as depicted by block 202. The value of "nw is incremented, as depicted in block 204, 
and processing continues until all of the mean amplitude values are processed, as 
indicated by decision block 206. The computer 92 then returns the computational flow 
to block 11 0 of Figure 3 as indicated by return block 208. 
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METHOD AND APPARATUS TO CHARACTERIZE 
ULTRASONICALLY REFLECTIVE CONTRAST AGENTS 
Abstract 
5 
A method and apparatus for characterizing the time and frequency response of 
an ultrasonically reflective contrast agent is disclosed. An ultrasonically reflective 
contrast agent is injected, under constant pressure, into a fluid flowing through a pump 
flow circuit. The fluid and the ultrasonically reflective contrast agent are uniformly 
10 mixed in a mixing chamber, and the uniform mixture is passed through a contrast agent 
chamber. The contrast agent chamber is acoustically and axially interposed between 
an ultrasonic transducer chamber and an acoustic isolation chamber. A pulse of 
ultrasonic energy is transmitted into the contrast agent chamber from the ultrasonic 
transducer chamber. An echo waveform is received from the ultrasonically reflective 
15 contrast agent, and it is analyzed to determine the time and frequency response of the 
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